机译:Voxelotor治疗患有镰状细胞疾病和非常严重的贫血患者
Sickle Cell BranchNational Heart Lung and Blood Institute National Institutes of HealthBethesda;
Sickle Cell BranchNational Heart Lung and Blood Institute National Institutes of HealthBethesda;
Laboratory of Chemical PhysicsNIDDK National Institutes of HealthBethesda Maryland;
Laboratory of Chemical PhysicsNIDDK National Institutes of HealthBethesda Maryland;
Laboratory of Chemical PhysicsNIDDK National Institutes of HealthBethesda Maryland;
Sickle Cell BranchNational Heart Lung and Blood Institute National Institutes of HealthBethesda;
Sickle Cell BranchNational Heart Lung and Blood Institute National Institutes of HealthBethesda;
Laboratory of Biochemistry and Vascular BiologyCenter for Biologics Evaluation and Research Food;
Laboratory of Chemical PhysicsNIDDK National Institutes of HealthBethesda Maryland;
Sickle Cell BranchNational Heart Lung and Blood Institute National Institutes of HealthBethesda;
机译:Voxelotor治疗患有镰状细胞疾病和非常严重的贫血患者
机译:类风湿性关节炎和镰状细胞性贫血患者的严重残疾报告不足,但可能可治疗的疾病组合
机译:拉丁美洲低收入国家中患有严重再生障碍性贫血和镰状细胞疾病的儿童的治疗:蒙扎国际儿科血液学/肿瘤学国际学校(MISPHO)最近会议的报告:第三部分。
机译:嵌入式系统在遗传病,镰状细胞性贫血中的应用
机译:利用疾病特异性诱导的多能干细胞对镰状细胞贫血进行建模。
机译:胎儿血红蛋白改善成年镰状细胞性贫血患者严重恶性疟原虫疟疾的疾病表现
机译:患有镰状细胞疾病和非常严重的贫血患者的毒素治疗